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What is already known about the topic?
•• Patients with life-limiting illness commonly experience considerable uncertainty, yet uncertainty is under-researched 
in the context of life-limiting illness.
•• Much of this uncertainty cannot be eliminated, yet clinicians are often reluctant to discuss uncertainty with their 
patients.
•• If poorly addressed, uncertainty can result in poorer psychological outcomes for patients and increase use of health-
care resources.
What this paper adds?
•• In-depth analysis of the experience of uncertainty for patients with a range of advanced illnesses.
•• Information needs, temporal focus and engagement with illness are key concerns for patients.
•• A typology of patient responses to uncertainty based on these three factors is developed to inform clinical 
practice.
How does uncertainty shape  
patient experience in advanced illness?  
A secondary analysis of qualitative data
Simon Noah Etkind, Katherine Bristowe, Katharine Bailey,  
Lucy Ellen Selman and Fliss EM Murtagh
Abstract
Background: Uncertainty is common in advanced illness but is infrequently studied in this context. If poorly addressed, uncertainty 
can lead to adverse patient outcomes.
Aim: We aimed to understand patient experiences of uncertainty in advanced illness and develop a typology of patients’ responses 
and preferences to inform practice.
Design: Secondary analysis of qualitative interview transcripts. Studies were assessed for inclusion and interviews were sampled using 
maximum-variation sampling. Analysis used a thematic approach with 10% of coding cross-checked to enhance reliability.
Setting/participants: Qualitative interviews from six studies including patients with heart failure, chronic obstructive pulmonary 
disease, renal disease, cancer and liver failure.
Results: A total of 30 transcripts were analysed. Median age was 75 (range, 43–95), 12 patients were women. The impact of 
uncertainty was frequently discussed: the main related themes were engagement with illness, information needs, patient priorities and 
the period of time that patients mainly focused their attention on (temporal focus). A typology of patient responses to uncertainty 
was developed from these themes.
Conclusion: Uncertainty influences patient experience in advanced illness through affecting patients’ information needs, preferences 
and future priorities for care. Our typology aids understanding of how patients with advanced illness respond to uncertainty. 
Assessment of these three factors may be a useful starting point to guide clinical assessment and shared decision making.
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Implications for practice, theory or policy
•• When managing patients with advanced illness and an uncertain prognosis, professionals should realise that uncer-
tainty is often a central feature of patients’ illness experience.
•• Our typology provides professionals with a framework to consider an individual patient’s preferences in terms of 
temporal focus, information needs and engagement with illness.
•• This may help to tailor discussions with patients so that patients’ priorities are addressed and information and  
support are provided according to their preferences.
Introduction
In our ageing population, an increasing number of people 
are living with advanced, life life-limiting illness.1 Their 
care and treatment are further complicated by multi-mor-
bidity and interactions between medical conditions. 
Patients can struggle with the complex healthcare system 
of which they become a part2 and may experience a great 
deal of uncertainty regarding what treatments are best, the 
nature of their illness and the future.3
The concept of uncertainty in illness has been widely 
studied3–7 and can be understood to consist of uncertainty 
in relation to medical, personal and social domains.8 
Most definitions agree that, in essence, uncertainty com-
prises the inability to attribute meaning to events.3,9 In 
her theory of uncertainty in illness, subsequently 
expanded to include chronic illness, Mishel4,5 argues that 
disease complexity, poor information provision and the 
unpredictability or ambiguity of events interfere with 
patients’ ability to confer meaning, thereby increasing 
uncertainty. Uncertainty is not necessarily a negative 
entity: it is patients’ appraisal and response to uncertainty 
that mediates its impact.5,7,10 For example, some patients 
will find prognostic uncertainty protective, as it allows 
them to ‘look on the bright side’, while others find not 
knowing what will happen distressing.
Research has mapped illness trajectories in several 
conditions,11,12 and much work has been undertaken in 
the field of prognostication.13,14 However, prognostica-
tion is based on professional judgement and inherently 
focuses on the clinician’s perspective,2,15 and there has 
been little attention to how patients themselves experi-
ence and cope with uncertainty in relation to prognosis. 
While experience of uncertainty has been investigated in 
some conditions,16 there is limited evidence related to 
patient experiences of uncertainty in advanced illnesses, 
in which trajectories are difficult to determine. Since 
uncertainty as to future illness course cannot be elimi-
nated, it is crucial to understand how patients with 
advanced illness cope with uncertainty and how uncer-
tainty affects their support needs and preferences for 
communication with healthcare providers.
We know that if uncertainty is poorly addressed and man-
aged, it can lead to negative emotional and psychological 
states for patients17–19 and affect care delivery.20 Unaddressed 
uncertainty may result in poor adaptation to illness,21 adverse 
coping strategies, such as searching unrealistically for medi-
cal certainty, and conflict with health professionals.22 
Unresolved emotional issues related to poor communication 
have been associated with higher use of healthcare services23 
and poor communication of the uncertainties of cancer treat-
ment with increased costs and higher risk of staff burnout.18 
Despite these effects, we know clinicians can be reluctant to 
raise uncertainty with patients,24–27 and this may be a reflec-
tion of current limits to medical education.
To address these negative outcomes and inform profes-
sionals’ training needs, we need greater understanding of 
how patients experience and respond to uncertainty in 
advanced illness. This study aimed to understand experi-
ences of uncertainty in patients with different advanced 
illnesses and develop a typology of their responses to 
uncertainty to inform future practice.
Methods
We undertook secondary analysis of in-depth qualitative 
interview data from studies including patients with a 
range of advanced illnesses. Available to us were inter-
views from six studies of patients with: heart failure, 
chronic obstructive pulmonary disease (COPD), motor 
neurone disease (MND), renal disease, liver disease and 
metastatic cancer and patients in intensive care. All stud-
ies investigated illness experience from a patient perspec-
tive. We followed the consolidated criteria for reporting 
qualitative research (COREQ) guidelines for reporting 
qualitative analyses as far as these apply to secondary 
analysis.28
Assessment for inclusion
Data from different studies must be carefully assessed and 
found to be comparable if they are to be analysed together. 
We used criteria adapted from Stewart and Kamins29 to 
assess whether it was reasonable to compare the studies 
based on study aim, data collection method, interview 
topic guide, data quality and timing of data collection 
(Figure 1). Suitability for inclusion was discussed within 
the multidisciplinary research group. Following this pro-
cess, two datasets were excluded: transcripts from the 
study in intensive care were not sufficiently relevant to the 
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aims of this analysis (criterion 1) and data from patients 
with MND did not contain sufficient detail (criterion 2).
Sampling/selection
Five datasets30–35 containing 98 interview transcripts were 
eligible for inclusion (Table 1). We screened all transcripts 
to identify those with content particularly relevant to the 
experience of uncertainty. This resulted in 73 transcripts 
with highly relevant or relevant content. We used purpo-
sive, maximum-variation sampling to select a sample of 30 
interviews from these 73 transcripts. Sampling was based 
on patients’ age, sex and diagnosis, with a preference for 
‘highly relevant’ over ‘relevant’ content.
Analysis
Interview transcripts were analysed thematically using 
a combination of inductive and deductive coding.36 
Thematic analysis was selected as the most appropriate 
approach to identify patterns and broad themes from the 
data.37 Following familiarisation with the data, one 
researcher (S.N.E.) developed the coding frame, with 
input from researchers who had conducted the analyses in 
the primary studies (K.B., L.E.S., F.E.M.M.) to finalise 
the coding frame. The researcher (S.N.E.) then applied the 
coding frame to the transcripts. During analysis, another 
researcher (K.Ba.) independently applied the coding 
frame to 10% of the transcripts. Discrepancies were 
resolved by discussion, with minor amendments to the 
coding frame. During analysis we recorded the new codes 
identified as each interview was analysed and considered 
that we had reached data saturation when no additional 
codes were identified. The final stage of analysis investi-
gated the themes to identify a typology of patient responses 
to uncertainty.36 This was verified by applying the typol-
ogy to the raw data and checking for fit.
Ethics
The secondary analysis was in line with the aims of the 
primary research studies and the original ethical approvals 
obtained. Additional approval for the secondary analysis 
was obtained from King’s College London Research and 
Development Service.
Results
Demographic characteristics
Interviews with 30 patients were analysed. A total of 12 
patients were women; median age was 75 years (range, 
43–95 years). The interviews included patients with heart 
failure (n = 10), COPD (n = 4), renal disease (n = 10), can-
cer (n = 5) and liver disease (n = 1) (Table 2)
Main themes
Four main themes emerged from the analysis, relating to: 
(a) patients’ engagement with the illness process, (b) the 
1. The purpose of the original study is relevant to the aims of this analysis.
2. The data collected are relevant and sufficient. I.e. the data collected to meet the original aims address the aim of 
the secondary analysis.
3. The method of data collection, data probity and quality are sufficient to allow analysis.
4. The time that has passed since the original data were collected is not felt to have distorted the relevance of the 
findings. 
5. The topic guides of the interview study are comparable to the aims of the secondary analysis, and to each other.
Figure 1. Inclusion criteria – assessment of comparability of qualitative data for secondary analysis.
Source: Adapted from Stewart and Kamins.29
Table 1. Details of included studies.
Study Population + sample Sample size
Renal study 132 Patients with advanced renal disease on conservative non 
dialytic pathway
16
Renal study 233 Patients with end-stage renal disease on haemodialysis 20
Heart failure study30,31 Patients with heart failure 20
AMBER care bundle evaluation35 Patients with uncertain recovery who are supported by the 
AMBER care bundle (cancer, renal disease, liver disease)
11
Breathlessness study34 Patients with cancer, COPD, MND and heart failure 
experiencing breathlessness
48 (31 suitable 
for inclusion)
COPD: chronic obstructive pulmonary disease; MND: motor neurone disease.
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period of time which patients mainly focused their atten-
tion on (denoted as ‘temporal focus’), (c) patients’ under-
standing of illness and information preferences and (d) 
patients’ priorities in the context of an uncertain future (see 
Figure 2). All four main themes were expressed by patients 
across the different disease groups.
Patients’ engagement with the illness process: control and loss 
of control. The theme of engagement relates to how 
involved patients wanted to be in illness decisions when 
prognosis was uncertain. In particular, some patients 
sought control over these decisions, and others ceded con-
trol to health professionals and/or family members. Some 
patients preferred to be strongly engaged with their care, 
either at a general or specific level:
Yes … really involved … they give me enough time to decide 
if I want … yes or no … they give me enough time … don’t 
know about anybody else but of myself … I’ve got enough 
time … they will even come back to ask me … but um … I 
can think about what they have said and so I’m happy with 
that. (A5CP3, 52-year-old male patient with cancer)
Others preferred to cede control over their treatment 
to health professionals. Several patients felt that it was 
inappropriate for them to be involved with treatment 
decisions:
They give me the tablets, I take the tablets, I go away, I’m 
quite happy if they’re working, I’m quite happy. It’s when 
they’re not working then I have to go and see a doctor – then 
you have to accept what the doctor’s going to do. (HF2a, 
59-year-old male patient with heart failure)
In addition to engaging with treatment decisions, some 
patients felt that maintaining independence in an uncertain 
future was a priority:
You know erm as long as, as long as I stay well and out of 
hospital and I can remain as independent as I can, keeping my 
indepen-, once my independence goes that will be me finished. 
I wouldn’t, I wouldn’t want people coming in here to wash 
me, dress me and that sort of thing … Once I’ve lost my 
independence that would be me. I would want, I would want 
the end stage to come quickly. (KP015, 72-year-old female 
patient with COPD)
Conversely, others were more concerned about areas 
where they had lost control over their lives due to illness. 
Some patients found it difficult to be limited by their illness:
Respondent:  When I walked out on the river front a 
couple of hours, stay out there, no prob-
lems at all! Now I, I have to, no, I ain’t 
going, I got that fear of going through 
that door, just in case something might 
happen between going down there and 
coming back again.
Interviewer:  So that’s a change for you … you’re 
quite anxious about -
Table 2. Demographic characteristics of sample.
Overall Patients with 
heart failure
Patients with 
renal disease
Patients 
with COPD
Patients 
with cancer
Patients with 
liver disease
n 30 10a 10b  4  5c  1
% female 40 20 40 75 50  0
Age (median) 75 72 83 69 62 43
Age (range) 43–95 57–80 59–95 54–75 52–84 –
COPD: chronic obstructive pulmonary disease.
aAll from heart failure study.
bSeven from renal study 1 and three from renal study 2.
cAll from AMBER care bundle evaluation.
Engagement with illness.
- Maintaining independence
- Control vs. loss of control
Temporal focus.
- Focus on the present
- Focus on the future
Information needs and preferences.
- Patients understanding of illness
- Complexity of illness experience
- Continuity of care
- Information preferences
- Full information vs. no information
Priorities.
- Appropriate communication
- Quality of life
- Social factors
- Practical planning 
- Family
- Avoiding isolation
- Conflict between patient and professional priorities
Figure 2. List of themes and sub-themes. Four main themes 
with list of sub-themes.
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Respondent:  I’m wary, very, very wary about goin’. 
(HF2a, 59-year-old male patient with 
heart failure)
Temporal focus: facing an uncertain future. This theme 
describes the period of time that patients were most 
focused on and in particular patients’ thoughts and feelings 
about their future. While some patients focused mainly on 
their current health status, others focused on future possi-
bilities. This was partly determined by clinical events; for 
example, patients receiving ongoing complex treatment 
tended to focus more on the present. Conversely, a recent 
serious illness event was associated with patients thinking 
more about the future; this was particularly apparent in the 
interviews with patients with heart failure. Some patients 
were attentive to both the present and the future. This is 
well illustrated in the interviews with patients with renal 
disease, where those receiving haemodialysis tended to be 
more focused on the present, while those receiving con-
servative care focused more on possible future events:
Interviewer:  Do you feel the staff give you enough 
opportunity to talk about your care in 
the future?
Respondent:  As I said, I don’t even think about that, 
I just take it day to day (HDMar, 
59-year-old female patient with renal 
disease on haemodialysis)
They said ‘Well you, you’ve got a bit of a kidney problem’. I 
don’t think it was very severe at that stage … but, but it, it’s 
gradually got worse since I’ve gone on, and now I’m told that 
I’m just on the borderline, if anything happens it won’t be 
very pleasant as it were … I accept that. (RG29, 84-year-old 
male patient with renal disease on conservative pathway)
Patients who considered their future did so in different 
ways. Some patients contemplated possible future scenarios 
such as deterioration or what might happen at the end of their 
lives. Others were more practical and considered in detail 
what might happen to their families or finances in future.
Information needs and preferences
Patients’ understanding of illness. Most patients under-
stood the ‘big picture’ of their likely prognosis. Several 
patients stated ‘I’m going to die’ when asked what the 
future held. However, patients expressed uncertainty 
about the illness journey ahead of them and the complexi-
ties of their treatment. Most patients described complex-
ity in their illness course. Many had multiple illnesses 
and were looked after by more than one healthcare team. 
Complexity frequently resulted in patients having poor 
understanding of their illness:
Interviewer:  Yeah … and do you feel they … they 
understand your concerns?
Respondent:  Yeah … oh yeah they’re very understand-
ing … I say when you’re in here they’re 
very, very good, very understanding, 
very helpful … it uh … it’s me that 
doesn’t understand. (ACPt4, 84-year-old 
male patient with cancer)
Some patients responded to this complexity by seeking 
information and engaging with their illness, whereas others 
disengaged from their illness entirely. Another group experi-
enced frustration at the complexities of illness, and this was 
sometimes expressed as concerns about continuity of care:
I always get confused when I go to hospital as to who is 
actually looking after me – you have a series of consultants or 
whatever they are, house you know, which … all very 
informative, they go round in a team and then one day one 
disappears one evening and I wonder who he was. (HF15a, 
75-year-old male patient with heart failure)
Information preferences. There was considerable varia-
tion in patients’ information preferences. At one end of the 
spectrum were patients who wished to be informed fully:
I’ve always find that if I ask them something they’ve told me 
straight forward! I’m not frightened of bad news. You know, 
and I’m not frightened. (HF9a, 69-year-old male patient with 
heart failure)
Others preferred to have no information about their ill-
ness, even if having more information might change their 
behaviour.
Interviewer:  Would you rather have not heard?
Respondent:  Yes (emphatic) … But mind you, I 
heard, [and] it is going to prolong my 
life because I [will] be more careful … 
but I would have preferred not to have 
heard.
Interviewer:  So there are advantages to hearing about 
it …
Respondent:  There are advantages, yes, because I am 
more careful.
Interviewer: But also disadvantages?
Respondent: Disadvantages, that’s it.
Interviewer: So on balance …?
Respondent:  On balance, not to tell me. [Very defi-
nite here] (RK21, 82-year-old male 
patient with renal disease)
Patient priorities in the context of an uncertain future. Patients 
were appreciative when their priorities were addressed by 
healthcare professionals. Patient priorities related to four 
areas: appropriate communication, quality versus quantity 
of life, social factors and co-morbidities. Patients wanted 
to get the amount of information about their illness that 
was right for them, communicated in the right way and 
 at Kings College London - ISS on May 9, 2016pmj.sagepub.comDownloaded from 
6 Palliative Medicine 
with the right people present. There were consequences if 
this procedure wasn’t followed:
Respondent:  and then one of the other ones of the 
team came in and out the blue he said 
we’re going to do a biopsy and if it’s 
um … malignant we can’t do anything
Interviewer:  Mmm …
Respondent:  So me son’s gone mad, he says he’s no 
right to say that to me without speaking 
to him first and he’s had a word with 
them … told them er what he thought 
and he said in future you contact me 
first … they came in the following day 
and did the same thing and it’s like 
nobody had anything positive, you 
know, it was all um gloom and doom. 
Well, of course you’ll have more bad 
days than good days … don’t want to be 
told that. (A3Cp1, 67-year-old female 
patient with cancer)
Most patients prioritised quality of life when making 
decisions about their care. Some were happy to sacrifice 
quantity of life for quality:
So that … I felt, in general, it wouldn’t alter my … I wouldn’t 
get such a, a good quality of life as I’m now getting. Now I 
understand that not having dialysis may reduce my life by … 
I don’t know, maybe six months or may even be a year, but I 
would have had all this time … good quality, I’ve got a very 
good quality, well you can see the cards, birthday. So I’ve got 
a very good quality of life. (RG29, 84-year-old male with 
renal disease on conservative pathway)
Several patients prioritised others over themselves 
when considering the future. For example, patients who 
were breadwinners for their family (in this sample, gener-
ally male) prioritised ensuring that their family were pro-
vided for after their death:
No it’s not really, it’s erm one of these questions that come up 
before in your mind but they’re not as medical er make sure 
the missus has enough money to survive on (laughs) erm or at 
least the children are erm (pause) come and see their mum 
more often than they do. (HF21a, 67-year-old male patient 
with heart failure)
Another, smaller group of patients felt that avoid-
ance of isolation was vital and considered social con-
tact a priority:
I’m not one to give in, I am not one to give in. I’ll fight it to 
the last but I just want that little bit of confidence … 
especially when you’re on your own, you’ve got no one to 
sort of tell people how you feel. (KP018, 75-year-old female 
with COPD)
A number of patients, predominantly with heart failure 
or on dialysis, prioritised health issues unrelated to their 
primary diagnosis, or features of living with illness they 
thought professionals considered unimportant. These pri-
orities were less likely to have been addressed than issues 
that were of more concern to professionals:
Respondent:  I can’t go out shopping
Interviewer:  So your kidney trouble stops you being 
able to … to do that.
Respondent:  Well it’s, no, it’s not the kidney trouble 
… it’s the arthritis. To be truthful I don’t 
even know I’ve got kidney trouble. 
[Patient receiving haemodialysis during 
interview] (RDAu, 82-year-old female 
patient on haemodialysis)
Other patients reported that health professionals priori-
tised unimportant issues and were often distressed by the 
conflict in priorities and lack of communication about this:
… the only problem is, they keep poking me and I know 
there’s no blood … well there’s blood left, but they don’t 
seem to realise I’ve got nowhere for them to poke anymore … 
so that’s the only thing I would say … leave me arms alone. 
(A10AP1, 56-year-old female with cancer)
Typology of patient responses to uncertainty
Based on the themes in our data, we developed a typol-
ogy of patient responses to uncertainty in advanced ill-
ness. Three factors determined patients’ response. First, 
patients had varying levels of engagement with their ill-
ness, treatment and the future, ranging from complete 
disengagement and delegation to medical professionals 
to close attention to all aspects of care. Second, in fac-
ing the future, patients’ temporal focus was on the pre-
sent, on possible future events, or, for some patients, on 
both. Finally, patients’ information preferences ranged 
from wanting to know all the facts to not wanting any 
information.
Three main types were seen: (a) patients who were dis-
engaged did not want information and focused on the pre-
sent, (b) patients who were fully engaged wanted full 
information and considered the present and future and (c) 
patients who expressed intermediate views on one or all of 
these scales (Figure 3).
Discussion
In this study, the first to explore patient experiences of 
uncertainty in depth across a range of advanced illnesses, 
we found that patients’ level of engagement with their ill-
ness, information preferences and temporal focus when 
facing the future are key factors in determining their 
response to uncertainty.
 at Kings College London - ISS on May 9, 2016pmj.sagepub.comDownloaded from 
Etkind et al. 7
We found that patients’ experiences of uncertainty and 
the priorities they expressed were remarkably similar 
across the disease groups. There were exceptions to this: in 
particular patients with heart failure or COPD more 
frequently described being affected by unpredictability (in 
line with the organ failure disease trajectory12). Patients 
with heart failure more commonly described a previous 
serious event and its impact. Finally, patients with renal 
3a) Disengaged, no information, focus on present
52 y/o male with cancer:   
“they always give us chances to ask questions if we want to 
[but]...to be quite honest...I don’t really talk about the future...
because I don’t know what is the future...I...I am a God 
fearing person...I put my trust in God...so if tomorrow is the 
end...or today is the end...I go...I like care about today...I don’t 
care about yesterday and tomorrow I ain’t going to make 
plans......so at the moment I’m not thinking anything about...
it’s like thinking about the future but I’ve got no plans...so I 
don’t involve nobody in thinking about my future.”
3b) Engaged, full information, focus on present & future
79 y/o male with heart failure:
“Interviewer: How do you feel in general about what doctors 
should do if they do have bad news to tell a patient, how you 
feel they should handle that?
Respondent: Ooh, ooh total must be told total honesty is all 
oh yeah that’s that’s that
Interviewer: Why do you think that’s so important?
Respondent: Well then you could know how to cope as I 
say things that I have no control over I don’t worry about if 
somebody says this will stop and the reasons why that’s fair 
enough I’ll accept that and then you can work round it.” 
3c) Engaged, partial information, focus on present
84  y/o male with renal disease: 
Respondent: And so I understand that I’m now, that’s it, you 
might, if you’re not having dialysis then you’re on the, on the 
ro, road down as it were .. and I understand that.
Interviewer: Do you appreciate that, [name]’s frankness or do 
you find it…?
Respondent: No, no, I’d rather have it.
Interviewer: You’d rather have it.
Respondent: Oh yes. Oh yes, I’d rather tell me straight what 
the si [situation is], but not what the future holds. I, I’m, I’m, 
I’d like to know, but I don’t think it was right to know. That’s, 
that’s how I see it.
Figure 3. Typology of patient responses to uncertainty with three examples (3 a,b,c). ‘Level of engagement’ describes the extent 
to which patients are actively involved in thinking about and making decisions about their illness. ‘Information preferences’ describes 
patient information preferences, ranging from preferring no information about illness to preferring full and detailed information. 
‘Temporal focus’ describes whether patients are focused on the future or on current events.
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failure who were receiving dialysis and patients with heart 
failure described more experiences of conflict between 
their own priorities and those of their medical team. These 
differences warrant further investigation in primary quali-
tative research studies. As the experience of uncertainty is 
not unique to patients, further research into caregiver 
experiences of uncertainty is also needed to shed light on 
how uncertainty affects caregivers.
Our findings are largely supportive of Mishel’s5 estab-
lished theory of uncertainty in illness, which specifies four 
underlying factors: complexity, unpredictability, lack of 
information and ambiguity. We have found complexity 
and unpredictability of illness to be a major part of the 
uncertainty experience for patients with advanced illness. 
Communication was a major theme, and this relates to the 
‘lack of information’ aspect of Mishel’s theory. The final 
aspect in Mishel’s classification, ‘ambiguity concerning 
the state of the illness’, occurs when patients are unclear as 
to the meaning of illness-related events, due to unfamiliar-
ity or complexity of events. This concept was considered 
less frequently by our patients and the reason for this is 
unclear. It may be that our secondary analysis design was 
insufficient to isolate ambiguity. Alternatively, it may be 
that once illness becomes advanced, there is less ambigu-
ity about the illness course itself, though other uncertain-
ties remain. Patients may also find it difficult to express 
their views on ambiguity or may attempt to attribute their 
own meanings to illness events to ‘cover up’ ambiguity.38 
There is some evidence that ambiguity in the context of 
advanced disease is an immobiliser – that it prevents 
understanding and hence limits expression and decision 
making.39,40 Further research investigating patient 
responses to ambiguity will help to clarify this.
Our typology of uncertainty also links well with 
existing theoretical positions. In their concept analysis 
of uncertainty, McCormick3 identified temporality as 
one of the key aspects of uncertainty, which corresponds 
to the temporal focus aspect of our typology. Research in 
renal disease has also highlighted the importance of tem-
porality to patients with advanced illness and an uncer-
tain trajectory.33 Mishel5 noted that lack of information 
was one key contributor to the appraisal of uncertainty, 
which is reflected in our model’s information needs fac-
tor. McCormick and Mishel identified other aspects of 
the construct of uncertainty in illness: complexity, 
unpredictability, ambiguity and the probability of events 
occurring. We found that patients engaged to different 
degrees with these aspects, resulting in level of engage-
ment as the third factor in our typology.
Our findings are highly relevant to clinical practice. 
Our typology provides professionals with a framework to 
gauge an individual patient’s preferences in three key 
areas. This may help to structure discussions with patients 
so that information and support are tailored to patients’ pri-
orities. By providing patients with appropriate levels of 
information, involving them in decision making according 
to their level of engagement, and discussing present and/or 
future care according to their temporal focus, clinicians 
may be able to better individualise the care of patients with 
uncertain prognosis. Considerable evidence exists regard-
ing communication and management of information pref-
erences in advanced illness, particularly in cancer care.41–43 
But there is less evidence regarding management of patient 
engagement. Shared decision-making approaches have 
proven effective,44 and patient activation approaches 
which aim to improve engagement have shown promise in 
other settings.45 Adaptation of these approaches to the con-
text of uncertain prognosis may help to shape practice. 
However, it is unclear whether we should aim to increase 
engagement or manage the existing level of patient engage-
ment. In future, the typology we propose here could be 
used to undertake a mixed-methods evaluation of the 
impact of considering these aspects of uncertainty on clini-
cal assessment and patient care.
Evidence suggests that professionals vary in their 
acknowledgement and recognition of uncertainty20,26,46 
and are often reluctant to discuss prognostic uncer-
tainty.25,26 Some have argued that this reflects inadequate 
training of healthcare professionals to deal with uncer-
tainty.47 Our findings concur with those of other studies 
demonstrating that patients frequently do want uncertainty 
to be made explicit.24,25 However, each patient’s priorities 
will be different, requiring an individually tailored 
approach. There are multiple factors involved in patients’ 
responses to uncertainty, which can be protective as well 
as harmful, and it is likely that professionals require more 
extensive training to enable them to effectively manage 
uncertainty. Future research should investigate profession-
als’ training needs in this area.
This study has both strengths and weaknesses. The 
secondary analysis design of this study allowed us to 
investigate the experience of uncertainty in a wide range 
of advanced illnesses and in a group of mixed age and 
gender. This increases the transferability of our findings 
and allows us to comment to some extent on the effects of 
different aspects of illness on the experience of uncer-
tainty. We were able to pursue a maximum-variation sam-
pling strategy while selecting transcripts containing the 
richest data relevant to our research questions. The input 
of authors of the primary studies ensured that the data 
were used appropriately and resulted in a more robust 
coding frame. The secondary design is a limitation, in 
that using data from different studies inevitably means 
differences between the transcripts analysed, despite our 
care to ensure the included studies were comparable. The 
secondary analysis approach means that we lacked con-
trol over what questions were asked; differences in prob-
ing between interviews resulted in richer data in some 
studies compared to others. We were particularly aware 
during analysis that data from the heart failure study were 
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very rich, while interviews with COPD patients included 
less probing and fewer follow-up questions.
Our sample included more male than female patients 
with heart failure, while the cancer patients formed a 
younger demographic. This, along with the absence of 
advanced neurological illness, means that our data are not 
representative of all patients with advanced illness, though 
the disease groups included were fairly well represented. 
Finally, the coding frame was applied by a single researcher 
with only 10% cross checking of coding; full dual coding 
would have increased rigour further.
Conclusion
Uncertainty is a key component of the illness experience 
for patients with advanced illness. The evidence-based 
typology we present allows us to better understand patient 
responses in situations of uncertainty and develop strate-
gies to address it in clinical practice. Better understanding 
and communication around uncertainty in the clinical set-
ting can improve information provision, help to engage 
and empower patients and facilitate patient-centred care.
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